论文部分内容阅读
体外膜肺氧合(extracorporeal membrane oxygenation,ECMO)作为一种有效的心肺支持治疗手段,可以减轻心肺功能负荷,有效改善低氧血症,避免长期高浓度氧吸入所致的氧中毒及机械通气的气道损伤,同时还可以为心脏功能提供暂时辅助支持,增加心排出量,改善全身循环灌注,维持心肺循环稳定,为心肺功能的恢复赢得时间~([1-2])。赵举等~([3])报道2002—2010年期间,在国内6家医疗中心,339例ECMO病例中,用于单纯呼吸支持65例,心脏支持248例,体外心肺复苏26例。总体
Extracorporeal membrane oxygenation (ECMO) as an effective cardiopulmonary support therapy can reduce the cardiopulmonary function load, effectively improve the hypoxemia and avoid long-term high concentration of oxygen inhalation caused by oxygen toxicity and mechanical ventilation Airway injury, but also can provide temporary support for cardiac function, increase cardiac output, improve systemic perfusion, and maintain the stability of cardiopulmonary circulation, for the recovery of cardiopulmonary function to win the time ~ ([1-2]). Zhao et al. ([3]) reported that during the period of 2002-2010, there were 65 cases of pure respiratory support, 248 cases of cardiac support and 26 cases of cardiopulmonary resuscitation in vitro in 6 medical centers and 339 ECMO cases in China. overall